Study uncovers consequences of molnupiravir use to treat COVID-19
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine.
Apr 8, 2024
0
69
New research from the University of Georgia suggests that something as simple as a cup of tea can help in the fight against COVID-19.
Apr 8, 2024
0
639
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a significant threat to public health and escalating the burden on health care resources. Characterized by the ...
Apr 3, 2024
0
24
A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models. This is the key finding of a recent publication in the Proceedings of the National Academy of Sciences ...
Apr 2, 2024
0
40
Taking a single pill that combines medications targeting cardiovascular disease-related conditions was shown long ago to lower the risk of death from such causes, including heart attacks and strokes.
Apr 1, 2024
0
31
Prolonged use of certain progestogen hormone drugs is associated with an increased risk of developing a type of brain tumor known as an intracranial meningioma, finds a study from France published by The BMJ today.
Mar 27, 2024
0
137
New research from the University of Pittsburgh and UPMC shows that telemedicine visits conducted for children with primary care providers (PCPs) are associated with fewer antibiotic prescriptions than telemedicine visits ...
Mar 19, 2024
0
9
Researchers at the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine, preventing it from effectively treating pancreatic ...
Mar 18, 2024
0
129
Rice University synthetic biologists have found a way to piggyback on the glucose monitoring technology used in automated insulin dosing systems and make it universally applicable for the monitoring and dosing of virtually ...
Mar 15, 2024
0
30